Sano Chemicals

Dr. Miles leads women’s health initiatives at Sano Chemicals Inc, where she leads business development efforts on female health products. Dr. Miles is an entrepreneur with over 30 years of clinical experience. She has a deep understanding of medical disorders and the need for new pharmacologic therapies to treat infectious diseases. She served on the Board of the Mississippi Gulf Coast Women’s Medical Association. She has a deep understanding of the clinical impact of antibiotic resistance, and particularly its impact on women’s health. She was the first woman Chief Fellow in her Pulmonary Disease Fellowship. Dr Miles has published research on clinical infectious diseases. Dr. Miles managed the manufacturing operations of Miles Osborn Inc. for over a decade. Dr. Miles received her Doctor of Osteopathy from Ohio University / College of Osteopathic Medicine. In addition to working approximately 15 hours a week for Sano Chemicals, Dr. Miles also works 30-50 hours per week as Owner, Physician, Sleep Center Director for Pulmonary and Sleep Medicine Sleep Lab.

Dr. Smith has over 20 years of scientific, operational, strategic and management experience in the biotech industry. He is a Full Professor in Biology and has been involved in the formation, product development, and leadership of several biotechnology companies over the last two decades. Dr. Smith holds more than 25 patents associated with antimicrobial and cancer therapeutics. He has authored over 50 peer-reviewed publications covering topics on drug discovery and antibiotic development. He previously held leadership roles as Product Leader for Oragenics Inc., contributing to the development of its antimicrobial product line. These product lines were used to leverage investments from government, private, and public sectors. In the early 2000s, he was Vice President of Ivigene Inc., which used a proprietary drug discovery platform for the identification of novel protein targets for vaccines and diagnostics products. Dr. Smith was the founder of Biotech Analyst Group, which provided an in-depth analysis of technologies and their related patents. He served as an Executive Director of the Able Trust Foundation in Tallahassee, FL for five years through a gubernatorial appointment. Dr. Smith has a Doctorate degree in Biochemistry from the College of Medicine at the University of Florida and an M.B.A. degree in Finance and Competitive Strategy from Warrington College of Business. Dr. Smith leads the overall strategy for Sano as well as runs the research and development team at the Sano Chemicals research facilities in Bryan, TX. In addition to working approximately 20 hours a week for Sano Chemicals, Dr. Smith also works 30-40 hours per week as a Professor for Texas A&M University.

Mr. Goodstein graduated with a BA in Accounting from the University of Washington in 1983. He has worked in public accounting and internal auditing, in the University of Copenhagen, Denmark International Program, and as a CPA in Anchorage Alaska. He is a QuickBooks Certified ProAdvisor, member of the CFO Leadership Council, and a Mass Challenge Austin Mentor.

Dr. Austin is a long-standing researcher in rare infections. Dr. Austin has over thirty years of mycology experience. He was the director of the Microbiological Diagnostic Laboratory at the College of Veterinary Medicine at Mississippi State University. He is a founding member of Sano Chemicals and supports drug development and fund-raising efforts.

Dr. Atiee received his medical degree from UTHSC San Antonio and has been involved in clinical pharmacology research for 23 years. He was Medical Director and Principal Investigator of Worldwide Clinical Trials’ 300 bed facility in San Antonio, Texas. He has worked as an Associate Medical Director for the clinical trial CRO Icon Development Solutions. He has performed and prepared IND applications for over 300 Phase 1 and 2 trials in multiple therapeutic areas. Dr. Atiee is instrumental to Sano where he leads the design and strategy of clinical protocols for our clinical trials.

Dr. Orugunty has two doctorate degrees from University of Florida in Medicinal Chemistry and Organic Chemistry. He is experienced with bioanalytical and analytical chemistry. He has extensive product development experience with his tenure at Cerilliant (EMD MilliporeSigma). Further, Ravi has extensive experience in bioanalytical method development and validation gained from his tenure with Worldwide Clinical Trials Inc. Dr. Orugunty's efforts will facilitate the development of novel therapeutic products in Sano's pipeline.

Mr. Tenorio graduated with a B.S. degree in the Department of Biology at Texas A&M University in 2018. He has experience working with large bioreactors. He brings GMP manufacturing practices and experience in upstream and downstream manufacturing processes. Has extensive experience in establishing and monitoring standard operating procedures and batch production records.

Mrs. Nair is responsible for safeguarding that products meet established quality standards. She identifies any potential issues in documentation or practices within the manufacturing processes. She monitors and maintains quality throughout the production cycle ensuring compliance with industry regulations.